Pharmacological modification of the serotonergic transmitter system and β-N-acetylhexosaminidase activity in rats

被引:4
|
作者
Casal, JA [1 ]
Corzo, MD
Pérez, LF
Alvarez, JA
Aldegunde, M
Tutor, JC
机构
[1] Hosp Clin Univ, Cent Lab, Santiago De Compostela 15706, Spain
[2] EuroEspes Ctr Med, Santa Marta Babio Bergon, Spain
[3] Univ Santiago de Compostela, Fac Biol, Lab Fisiol Anim, Santiago De Compostela, Spain
关键词
beta-N-acetylhexosaminidase; enzyme heterogeneity; serotonin status;
D O I
10.1016/S0024-3205(00)00817-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The enzyme activity and activation energy of plasma beta-N-acetylhexosaminidase (Hex) was determined in rats whose serotonergic system had been pharmacologically altered. In the group of animals treated with 5-hydroxytryptophan, in the different dissected brain regions (brain stem, cortex and hippocampus) significantly higher levels of serotonin and 5-hydroxyindolacetic acid were found, and significantly lower in the group treated with p-chlorophenylalanine. than in the control group. In the total number of animals studied (n = 21), a statistically significant correlation was found between the plasma concentration of 5-hydroxyindolacetic acid and the levels of this metabolite in the different brain regions (p < 0.001). No significant differences were found for the activity of Hex in the plasma, or for its activation energy, which is a marker of its isoenzyme composition, among the three groups of animals. The results obtained using our experimental model in rats do not confirm the hypothesis of other authors who suggest that the Hex responds secondary to increases or decreases of serotonin turnover, and could be a biological test to monitor the serotonin status in psychiatric patients. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:2369 / 2374
页数:6
相关论文
共 38 条
  • [1] β-N-acetylhexosaminidase activity and isoenzyme profile in the kidney and urine of trained rats
    Tassi, C
    Mancuso, F
    Gambelunghe, C
    Rufini, S
    Feligioni, L
    Biondi, R
    Rossi, R
    Capodicasa, E
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2001, 23 (04) : 573 - 583
  • [2] Distinguishing Candida species by β-N-acetylhexosaminidase activity
    Niimi, K
    Shepherd, MG
    Cannon, RD
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (06) : 2089 - 2097
  • [3] Elevated β-N-acetylhexosaminidase activity in focal dystonia fibroblasts
    Costanzi, E
    Beccari, T
    Tassi, C
    Orlacchio, A
    Rossi, A
    CLINICA CHIMICA ACTA, 1999, 288 (1-2) : 31 - 35
  • [4] Age dependence of serum β-N-acetylhexosaminidase (NAG) activity
    Oláh, AV
    Price, RG
    Csáthy, L
    Országh, É
    Oláh, É
    Varga, J
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (03) : 305 - 306
  • [5] Loop Protein Engineering for Improved Transglycosylation Activity of a β-N-Acetylhexosaminidase
    Jamek, Shariza B.
    Muschiol, Jan
    Holck, Jesper
    Zeuner, Birgitte
    Busk, Peter K.
    Mikkelsen, Jorn D.
    Meyer, Anne S.
    CHEMBIOCHEM, 2018, 19 (17) : 1858 - 1865
  • [6] Phenotypic switching and β-N-acetylhexosaminidase activity of the pathogenic yeast Trichosporon asahii
    Ichikawa, T
    Sugita, T
    Wang, L
    Yokoyama, K
    Nishimura, K
    Nishikawa, A
    MICROBIOLOGY AND IMMUNOLOGY, 2004, 48 (04) : 237 - 242
  • [7] Plasma and peripheral leukocyte β-N-acetylhexosaminidase isoenzymes and disease activity in rheumatoid arthritis
    Casal, JA
    Mera, A
    Pérez, LF
    Tutor, JC
    CLINICAL BIOCHEMISTRY, 2002, 35 (06) : 483 - 488
  • [8] Mechanisms Underlying Modulation of the Pharmacological Properties of Pegylated Erythropoietin by Pegylated Hyaluronate-Endo-β-N-Acetylhexosaminidase
    Dygai, A. M.
    Zyuz'kov, G. N.
    Zhdanov, V. V.
    Udut, E. V.
    Miroshnichenko, L. A.
    Simanina, E. V.
    Gurto, R. V.
    Minakova, M. Ju.
    Chaikovsky, A. V.
    Markova, T. S.
    Stavrova, L. A.
    Artamonov, A. V.
    Bekarev, A. A.
    Madonov, P. G.
    Kinsht, D. N.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2013, 154 (06) : 750 - 754
  • [9] DETECTION OF TAY-SACHS DISEASE CARRIERS BY DETERMINATION OF N-ACETYLHEXOSAMINIDASE A ACTIVITY IN BLOOD
    TSVETKOV.IV
    KOZINA, AB
    VOPROSY MEDITSINSKOI KHIMII, 1974, 20 (06): : 631 - 634
  • [10] Pyrimethamine Derivatives: Insight into Binding Mechanism and Improved Enhancement of Mutant β-N-acetylhexosaminidase Activity
    Tropak, Michael B.
    Zhang, Jianmin
    Yonekawa, Sayuri
    Rigat, Brigitte A.
    Aulakh, Virender S.
    Smith, Matthew R.
    Hwang, Hee-Jong
    Ciufolini, Marco A.
    Mahuran, Don J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (11) : 4483 - 4493